Skip to main content

Table 1 Patient characteristics according to CRLM status (resected or unresected)

From: Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study

Variables

Total (n = 105)

Resected CRLM (n = 49)

Unresected CRLM (n = 56)

P value

Gender

 Male

51 (49%)

20 (41%)

31 (55%)

0.1369

 Female

54 (51%)

29 (59%)

25 (45%)

Age

65 years

42 (40%)

20 (41%)

22 (39%)

0.8731

>65 years

63 (60%)

29 (59%)

34 (61%)

Primary tumor site

 Right-sided

56 (55%)

26 (54%)

30 (56%)

0.0911

 Left-sided

28 (27%)

17 (36%)

11 (20%)

 Rectum

18 (18%)

5 (10%)

13 (24%)

 Missing data

3

1

2

Primary tumor surgery

 Yes

79 (75%)

49 (100%)

30 (54%)

< 0.0001

 No

26 (25%)

0

26 (46%)

T stage

 T1–T2

4 (5%)

4 (8%)

0

0.2909

 T3–T4

73 (95%)

44 (92%)

29 (100%)

 Missing data

28

1

27

N stage

 N0

9 (12%)

7 (15%)

2 (7%)

0.4699

 N1–N2

68 (88%)

41 (85%)

27 (93%)

 Missing data

28

1

27

CRLM time of diagnosis

 Synchronous

94 (90%)

41 (84%)

53 (95%)

0.0671

 Metachronous

11 (10%)

8 (16%)

3 (5%)

CRLM distribution

 Unilobar

33 (39%)

21 (57%)

12 (26%)

0.0036

 Bilobar

51 (61%)

16 (43%)

35 (74%)

 Missing data

21

12

9

Number of CRLM

 <10

56 (70%)

32 (89%)

24 (55%)

< 0.0001

10

24 (30%)

4 (11%)

20 (45%)

 Missing data

25

13

12

Initial resectability

 Yes

43 (52%)

32 (86%)

11 (24%)

< 0.0001

 No

39 (48%)

5 (14%)

34 (76%)

 Missing data

23

12

11

RAS status

 Wild-type

103 (99%)

47 (98%)

56 (100%)

0.4615

 Mutant

1 (1%)

1 (2%)

0

 Missing data

1

1

-

MSI-H

 Yes

21 (30%)

14 (29%)

7 (33%)

0.7293

 No

48 (70%)

34 (71%)

14 (67%)

 Missing data

36

1

35

Resection margin status

 R0

32 (89%)

32 (89%)

NC

 

 R1 parenchymal

4 (11%)

4 (11%)

NC

 R1 vascular

0

0

NC

 Missing data

13

13

 
  1. CRLM Colorectal liver metastases, MSI-H Microsatellite instability. χ2 or Fisher’s exact test was applied for groups comparisons. NC Not concerned